Clinical Roundup Similar results reported in comparison of pirtobrutinib vs. ibrutinib to treat CLL, SLL, OSU study finds December 19, 2025Vol.51 No.46
Clinical Roundup Retifanlimab-dlwr demonstrates 11-month OS difference for anal cancer patients in phase III trial December 19, 2025Vol.51 No.46
Clinical Roundup Cedars-Sinai researchers develop risk score to help predict pancreatic cancer recurrence December 19, 2025Vol.51 No.46
Clinical Roundup Drug combination kills OVCAR3 ovarian cancer cells, UNM researchers find December 19, 2025Vol.51 No.46
Clinical Roundup Blood test detects lung cancer up to 5 years before scans, Personalis and University College London study finds December 19, 2025Vol.51 No.46
Clinical Roundup ECOG-ACRIN, Caris present breast cancer recurrence and risk stratification AI tools December 12, 2025Vol.51 No.45
Clinical Roundup ACS updates guidelines for cervical cancer screening December 12, 2025Vol.51 No.45By Claire Marie Porter
Clinical Roundup Off-the-shelf immunotherapy produces deep and durable responses in extramedulary MM, Mayo researchers find December 12, 2025Vol.51 No.45
Clinical Roundup Eflornithine + lomustine extend OS for patients with recurrent IDH mutant, grade 3 astrocytoma, phase III data show December 12, 2025Vol.51 No.45
Clinical Roundup Mental health conditions increase liver cancer risk in veterans, UCLA-led study finds December 12, 2025Vol.51 No.45
